Webdisclosure.com

ZOMEDICA CORP. (NYSE:ZOM)

06/12/2023 12:30

Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

28/11/2023 12:30

Zomedica to Present at Noble Capital Markets' 19th Annual Emerging Growth Equity Conference

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

20/11/2023 12:30

Zomedica to Present at the 35th Annual Piper Sandler Healthcare Conference

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

13/11/2023 22:20

Zomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6.3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo Biotechnologies

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

02/11/2023 11:30

Zomedica to Report Third Quarter 2023 Financial Results and Provide Business Update on November 13 at 4:30 p.m. ET

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

10/10/2023 06:00

Zomedica to Participate in the Lytham Partners Fall 2023 Investor Conference

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

05/10/2023 12:30

Zomedica Announces Acquisition of TRUFORMA Platform Developer Qorvo Biotech LLC, Accelerating Timeline to Gain Control of Manufacturing and Research & Development

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

14/09/2023 12:30

Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of First-and-only Point of Care eACTH Assay for Diagnosis and Management of Cushing’s Disease in Horses

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

13/09/2023 22:30

Zomedica Provides Corporate Update

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

05/09/2023 22:30

Zomedica Closes Acquisition of Structured Monitoring Products Adding Revolutionary VetGuardian Touchless Vital Signs Monitor to Product Portfolio

Voir tous les communiqués de Zomedica Corp.

1
2
3
4
5
6
7
8
9
10